Side-by-side comparison of AI visibility scores, market position, and capabilities
Benchling is a life sciences R&D cloud platform with ~$200M+ ARR. Series E startup valued at ~$6.1B. Trusted by Pfizer, Genentech, and 1,000+ biotech/pharma teams. HQ: San Francisco.
Benchling is a cloud-based research and development platform purpose-built for the life sciences industry, founded in 2012 by Sajith Wickramasekara and Ashu Singhal as a Y Combinator alumnus. The company offers an integrated suite of tools including electronic lab notebooks (ELN), laboratory information management systems (LIMS), molecular biology design tools, and data management platforms, all connected in a unified cloud environment.
GPT-5 and o3 model family at $25B+ ARR; $840B post-money valuation (Feb 2026 round); ChatGPT 1B+ users; largest private fundraise in history ($110B). Competing with Anthropic Claude 4, Google Gemini 3, Meta Llama 4.
OpenAI is a San Francisco-based artificial intelligence company developing and deploying large-scale AI systems — including GPT-4o, o1 reasoning models, DALL-E 3 image generation, Sora video generation, and the Whisper speech recognition model — through the ChatGPT consumer product and OpenAI API for developers and enterprise customers. Founded in 2015 as a nonprofit by Sam Altman, Elon Musk, Greg Brockman, and others and restructured into a capped-profit company, OpenAI raised $157 billion in total funding including a $6.6 billion round in October 2024 at a $157 billion valuation and a $40 billion round from SoftBank in 2025, generating $3.7 billion in annualized revenue in 2024 with 400 million weekly ChatGPT users.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.